Home / Inspections / 1167592

FDA Inspection 1167592 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 1971882

The FDA completed an inspection of Biomat USA, Inc. on March 17, 2022 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 17, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Saint Louis, MO (United States)

Facility

Other inspections at this facility

  • 1015150 (NAI Wed Jun 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903957 (NAI Fri Nov 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805513 (NAI Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 722053 (NAI Wed Apr 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 578255 (NAI Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources